Alice Blue - 20 years of trust
    • ANT APP
    • ANT WEB
    • 1LyAlgos
    • 1lyOptions
    • TradingView
    • MTF
    • Insurance
    • IPO
    • Stocks
    • Mutual Funds
    • US Stocks
  • Partner with us
  • Trade School
  • Pricing

    • Pricing

    About Us

    • About Us

    Calculator

    • Calculators
    • Brokerage Calculator
    • MTF Calculator

    Resources

    • Blog
    • Webinars
    • Videos (YouTube)

    Updates

    • News
    • Trading Holidays
    • Cares
    • Media Coverage
    • Disclosures

    Support

    • Support
    • Refer & Earn
    CommunityCareers
Login

    Start Investing in Stocks₹0 Account Opening

    +91
    Top Gainers Today52 Weeks High StocksHistorical Returns StocksShare Market TodayTop Losers TodayStocks Market NewsPC JewellerVodafone IdeaTata Gold ETFNip. India GoldNippon I SilverYes BankTata Silver ETFHMA Agro Inds.V2 RetailUgro CapitalHDFC BankDSP Gold ETFICICI Gold ETFZerodha Gold ETFSuzlon EnergyTata SteelCanara BankMoneyviewSagility
    NIFTY 50NIFTY Midcap 100NIFTY 100NIFTY RealtySENSEXNIFTY AutoNIFTY PSU BankNIFTY FMCGNIFTY BANKNIFTY MIDCAP 150BSE EnergyNIFTY PharmaBSE 100 LargeCap TMCNIFTY NEXT 50NIFTY MetalBSE 500 QUALITY 50
    Options Nifty 50Options BANK NIFTYOptions MIDCPNIFTYOptions FINNIFTYFutures Highest OIFutures OI GainersFutures OI LosersFutures Top Traded
    Debt Mutual FundsBest Debt Mutual fundsBest Equity Mutual fundsBest Hybrid Mutual fundsBest MidCap Mutual fundsBest Multicap Mutual fundsBest Large Cap Mutual fundsBest Small Cap Mutual fundsBest ELSS Mutual fundsBest Contra Mutual fundsBest Value Mutual fundsBest Arbitrage Mutual fundsBest Dividend Yield Mutual fundBest Aggressive Mutual fundsBest Conservative Mutual funds
    SIP CalculatorBrokerage CalculatorHome Loan EMI CalculatorLumpsum CalculatorMargin CalculatorFD CalculatorSWP CalculatorMF CalculatorEMI CalculatorStep-Up SIP CalculatorPPF Calculator
    What Is IPO?Open IPOsUpcoming IPOsHow to Apply for an IPOWhat is Grey Market Premium?
    Shares
    Top Gainers Today52 Weeks High StocksHistorical Returns StocksShare Market TodayTop Losers TodayStocks Market NewsPC JewellerVodafone IdeaTata Gold ETFNip. India GoldNippon I SilverYes BankTata Silver ETFHMA Agro Inds.V2 RetailUgro CapitalHDFC BankDSP Gold ETFICICI Gold ETFZerodha Gold ETFSuzlon EnergyTata SteelCanara BankMoneyviewSagility
    Indices
    NIFTY 50NIFTY Midcap 100NIFTY 100NIFTY RealtySENSEXNIFTY AutoNIFTY PSU BankNIFTY FMCGNIFTY BANKNIFTY MIDCAP 150BSE EnergyNIFTY PharmaBSE 100 LargeCap TMCNIFTY NEXT 50NIFTY MetalBSE 500 QUALITY 50
    F&O
    Options Nifty 50Options BANK NIFTYOptions MIDCPNIFTYOptions FINNIFTYFutures Highest OIFutures OI GainersFutures OI LosersFutures Top Traded
    Mutual Funds
    Debt Mutual FundsBest Debt Mutual fundsBest Equity Mutual fundsBest Hybrid Mutual fundsBest MidCap Mutual fundsBest Multicap Mutual fundsBest Large Cap Mutual fundsBest Small Cap Mutual fundsBest ELSS Mutual fundsBest Contra Mutual fundsBest Value Mutual fundsBest Arbitrage Mutual fundsBest Dividend Yield Mutual fundBest Aggressive Mutual fundsBest Conservative Mutual funds
    Calculators
    SIP CalculatorBrokerage CalculatorHome Loan EMI CalculatorLumpsum CalculatorMargin CalculatorFD CalculatorSWP CalculatorMF CalculatorEMI CalculatorStep-Up SIP CalculatorPPF Calculator
    IPO
    What Is IPO?Open IPOsUpcoming IPOsHow to Apply for an IPOWhat is Grey Market Premium?

    Company
    • About Us
    • Work with Us
    • Terms and Conditions
    • EKYC Guidelines
    • Contact Us
    • Cares
    Apps and Products
    • ANT APP
    • ANT WEB
    • 1LYOptions
    • Trade School
    • TradingView
    • 1LyAlgos
    • US Stocks
    Calculators
    • Calculators
    • SIP Calculator
    • Mutual Funds Return Calculator
    • Brokerage Calculator
    • RMS Live Updates
    • Term Coverage Calculator
    Important Links
    • Pricing
    • KYC Tracker
    • Market News
    • Global Indices
    • Gold Rate
    • Silver Rate
    • Trading Holidays

    Alice Blue
    3rd Floor, M.R.B.Arcade, No. 153/2,
    Bagalur Main Rd, Dwarka Nagar,
    Yelahanka, Bengaluru, Karnataka
    560063
    FacebookLinkedInX (Twitter)YouTubeInstagramWhatsapp

    ISO 27001:2022 Alice Blue is Certified Information Security Management System (ISMS)

    ISO 22301:2019 Alice Blue is Certified Business Continuity Management System (BCMS)

    DownloadsCircularsBank DetailsLearn
    Trade on TradingViewGet it on Google PlayDownload on the App Store

    Attention Investors!
    Prevent unauthorized transactions in your account update your mobile number/ email Id with your Stock Broker. Receive information of your transactions directly from Exchange on your mobile / email id at the end of the day.Prevent unauthorized transactions in your account update your mobile number/ email Id with your Stock Broker. Receive information of your transactions directly from Exchange on your mobile / email id at the end of the day.

    Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from the depository on your email id and/or mobile number to create a pledge. Pay 20% upfront margin of the transaction early to trade in the cash market segment. Investors may please refer to the Exchange’s Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020, and NSE/INSP/45534 dated August 31, 2020, and other guidelines issued from time to time in this regard. Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month.

    Corporate Office: No. 153/2, 3rd Floor, M.R.B.Arcade, Bagalur Main Road, Dwaraka Nagar, Yelahanka, Bengaluru – 560 063, Karnataka.
    Registered Office: Old No.56/2 ,New No.58, LIC Nagar, Vinayagar Kovil Street, Erode -8,Tamil Nadu– 638002.
    Alice Blue Financial Services (P) Ltd : NSE EQ | NSE FO | NSE CDS-90112 SEBI REG : INZ000156038
    Alice Blue Financial Services (P) Ltd : BSE EQ | BSE FO | BSE CD-6670 SEBI REG : INZ000156038
    Alice Blue Financial Services (P) Ltd : CDSL DP ID 12085300 DP SEBI REG : IN-DP-364-2018
    Alice Blue Financial Services (P) Ltd : MCX-56710 SEBI REG : INZ000156038

    COMPLIANCE OFFICER: SARAVANAN R | Mobile No: +91 91872 10670 | Email:[email protected]

    We hereby declare that we are doing PRO trading

    Procedure to file a complaint on SEBI SCORES / SMART ODR : Register on SEBI SCORES 2.0 / SMART ODR. Mandatory details for filing complaints on SCORES: Name, PAN, Address, Mobile Number, E-mail ID. Benefits: Effective Communication, Speedy redressal of the grievances

    Click on the provided link to learn about the process for submitting a complaint on the ODR platform for resolving investor grievances. ODR Circular

    Investment in securities markets are subject to market risks, read all the related documents carefully before investing. Brokerage will not exceed SEBI prescribed limit.

    For queries regarding account opening or activation, email to accountactivation@aliceblueindia.com and for fund updates, email to funds@aliceblueindia.com

    Disclaimer: Attention investors:1) Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors. 2) Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary. 3) Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors. 4) For demat and trading account closure with AliceBlue, kindly visit https://aliceblueonline.com/support/closure-freezing-reactivation or “ANT APPLICATION” under your profile and click on Settings -> Account Closure section -> Initiate account closure.

    No need to issue cheques by investors while subscribing to an IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in the investor’s account.

    Investors are requested to note that Alice Blue Financial Services Private Limited is permitted to receive money from investor through designated bank accounts only named as Up streaming Client Nodal Bank Account (USCNBA). Alice Blue Financial Services Private Limited is also required to disclose these USCNB accounts to Stock Exchange. Hence, you are requested to use following USCNB accounts only for the purpose of dealings in your trading account with us. The details of these USCNB accounts are also displayed by Stock Exchanges on their website under “Know/ Locate your Stock Broker. Bank Details (Valid UPI FAQ).

    DND PolicyInvestor CharterLegal DocumentationPrivacy policyFeedbackAnnual ReturnsAdvisory for InvestorsE-votingMandatory Member Details

    Performance

    Historical price movement and trading activity

    Trading Data

    Today's High

    520.05

    Today's Low

    511.05

    Open

    516.25

    Previous Close

    517.6

    Volume

    203308

    Total Traded Value High

    104768506.85

    Technicals

    Price-based indicators and levels

    Indicators

    IndicatorValueSignal
    Relative Strength Index (RSI)+46.78Neutral
    MACD-2.27Bearish

    Support and Resistance Levels

    R3540.42
    R2533.68
    R1525.27
    S1510.12
    S2503.38
    S3494.97

    Moving Averages

    PeriodSMAEMA
    20D Moving Average523.20525.01
    50D Moving Average534.71533.35
    200D Moving Average492.88536.68
    Blue Jet Healthcare Ltd

    Blue Jet Healthcare Ltd

    NSE: BLUEJET | BSE: 544009
    ₹517.6+0.75 (0.15%)
    BuySell

    News

    Blue Jet Healthcare gains after launching QIP; floor price set at Rs 531.70/share

    7 Jul 2026

    Blue Jet Healthcare rose 1.26% to Rs 570.60 after the company announced the launch of its qualified institutional placement (QIP) issue and fixed the floor price at Rs 531.70 per equity share.

    The company's authorisation and allotment committee approved the opening of the issue on 6 July 2026. The floor price of Rs 531.70 is at a discount of 5.64% to the scrip's previous closing price of Rs 563.50 on the BSE. The company may offer a discount of not more than 5% on the floor price so calculated for the issue. The issue price will be determined in consultation with the bookrunning lead managers appointed for the issue. Blue Jet Healthcare is a speciality pharmaceutical and healthcare ingredient company and an end-to-end integrated Contract Development and Manufacturing Organisation (CDMO). On a standalone basis, the company reported a net profit of Rs 64.34 crore in Q4 FY26, down 41.56% year-on-year (YoY) but up 60.17% quarter-on-quarter (QoQ). Revenue from operations declined 31.07% YoY to Rs 234.67 crore in Q4 FY26 due to negligible sales of one molecule in the PI vertical. However, revenue increased 21.96% QoQ from Rs 192.41 crore, driven by higher sales of advanced contrast media. Powered by Capital Market - Live News

    Blue Jet Healthcare jumps as Q4 PAT jumps 60% QoQ

    26 May 2026

    Blue Jet Healthcare surged 6.26% to Rs 511.55 after the company reported strong sequential improvement in quarterly earnings.

    On a standalone basis, the company reported a net profit of Rs 64.34 crore in Q4 FY26, down 41.56% YoY but rising 60.17% QoQ. Revenue from operations declined 31.07% YoY to Rs 234.67 crore in Q4 FY26 due to negligible sales of one molecule in the PI vertical. However, revenue increased 21.96% QoQ from Rs 192.41 crore driven by higher sales of advance contrast media. The company said the YoY decline in revenue reflected timing-related order phasing in select PI accounts and customer-side inventory normalization. However, management maintained that underlying demand visibility remains strong and expects normalization in upcoming quarters. Gross profit stood at Rs 132.5 crore in Q4 FY26, down 29.2% YoY but up 33% QoQ. Gross margin improved to 56.4% from 51.7% in Q3 FY26, supported by favourable product mix and higher sales of contrast media intermediates. Profit before tax stood at Rs 87.15 crore in Q4 FY26, down 40.8% YoY while rising 62.05% QoQ. EBITDA stood at Rs 71.3 crore in Q4 FY26, down 49.1% YoY but increasing 52% QoQ. EBITDA margin improved to 30.4% from 24.4% in Q3 FY26. On the cost front, raw material costs declined 43.18% YoY to Rs 92.89 crore, while employee expenses increased 15.57% YoY to Rs 18.48 crore. Interest costs rose sharply to Rs 0.58 crore from Rs 0.03 crore a year ago, while depreciation expenses increased 30.51% YoY to Rs 6.46 crore. For the full year FY26, net profit declined 18.8% YoY to Rs 247.82 crore, while revenue fell 8.03% YoY to Rs 947.32 crore. PBT for FY26 declined 18.12% YoY to Rs 332.51 crore. EBITDA for FY26 stood at Rs 294.1 crore, down 22.1% YoY, while EBITDA margin moderated to 31% from 36.7% in FY25. Net cash flow from operating activities improved sharply to Rs 334.14 crore in FY26 from Rs 45.76 crore in FY25. The board recommended a final dividend of Rs 1.2 per equity share of the face value of Rs 2 each for the Financial Year ended 31 March 2026. Blue Jet Healthcare is a specialty pharmaceutical and healthcare ingredient company and an end-to-end integrated Contract Development and Manufacturing Organisation (CDMO). Powered by Capital Market - Live News

    Trade now

    Overview

    Pharmaceuticals - Indian - Bulk Drugs & Formln M/SNSE / BSE

    Blue Jet Healthcare Limited was originally incorporated as Jet Chemicals Private Limited,' at Mumbai, dated December 7, 1968. The Company name was changed to Blue Jet Healthcare Private Limited', and a fresh Certificate of Incorporation dated December 30, 2020, was issued by the Registrar of Companies, Mumbai. Subsequently, the status got converted into a Limited Company and its name was changed to Blue Jet Healthcare Limited' on May 18, 2022. The Company is a global, science-led, pharmaceutical company evolved as strategic partner for Collaboration, Development & Manufacturing of Advance Pharmaceutical Intermediates and API. It operate into 3 product categories, contrast media intermediates, high- intensity sweeteners, and pharma intermediates and active pharmaceutical ingredients (APIs). It is engaged in manufacturing of Pharma Intermediate, APIs used in Pharmaceutical and Healthcare products. Since incorporation in 1968, the Company was established with the name Jet Chemicals Private Limited' in Shahad (Unit I) by Late Shri B L Arora. At present, Company has been expanded to include contract development and manufacturing organization (CDMO) business model with specialized chemistry capabilities in contrast media intermediates and high intensity. In 1970, the Company began manufacturing saccharin and its salts, which are high-intensity sweeteners. In 2000, it entered the X-ray contrast media sector, with a basic building block (5- NIPA). In 2002, it started manufacturing of pharma intermediates and API. In 2003, it established Blue Circle Organics Private Limited at their Unit-II, Ambernath facility. In 2017, it started semi-automated manufacturing block for their contrast media intermediate business. The National Company Law Tribunal at Mumbai (NCLT), by way of its Order dated November 19, 2020, sanctioned a Scheme of Merger amongst the Company, Blue Circle Organics Private Limited and their respective shareholders, and creditors and made it effective from December 28, 2020. In 2020 it acquired a Unit III brownfield site in Mahad. In 2021, it acquired a Unit IV 'greenfield' manufacturing site in Ambernath. The Company made an Offer for Sale of issuing 24,285,160 Equity Shares of Rs 2/- each by raising funds aggregating to Rs 84 Crore in October, 2023. In 2024, Company launched a new product in the PI/API division for a cardiovascular innovator, with rise in pharmacy benefits. Company commissioned 120 KL capacity Plant 6 at Ambernath in 2025. The Company commenced greenfield expansion project at Vizag in 2026.

    Fundamentals

    Financial strength and ownership structure

    Valuation & Ratios

    Market Capitalisation

    ₹0.00

    Price to Book (PB)

    0.00

    Price to Earnings (PE)

    0.00

    Return on Equity (ROE)

    50.18%

    Earnings Per Share (EPS)

    1,369.93

    Dividend Yield

    0.00%

    Financial Performance

    Shareholding Pattern

    79.81%
    73.14%
    73.14%
    73.14%
    Mar
    '26
    Jun
    '26
    Jul
    '26
    Sep
    '26